Douglas Lane & Associates, LLC Abbott Laboratories Transaction History

Douglas Lane & Associates, LLC

  • $6.89 Billion
  • Q2 2024

A detailed history of Douglas Lane & Associates, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 16,127 shares of ABT stock, worth $1.88 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
16,127
Previous 15,704 2.69%
Holding current value
$1.88 Million
Previous $1.78 Million 6.11%
% of portfolio
0.02%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 08, 2024
BUY
$100.73 - $112.44 $42,608 - $47,562
423 Added 2.69%
16,127 $1.68 Million
Q1 2024

Apr 11, 2024
SELL
$109.52 - $120.96 $45,669 - $50,440
-417 Reduced 2.59%
15,704 $1.78 Million
Q4 2023

Jan 17, 2024
SELL
$90.19 - $110.4 $62,050 - $75,955
-688 Reduced 4.09%
16,121 $1.77 Million
Q3 2023

Oct 16, 2023
BUY
$95.53 - $114.62 $69,259 - $83,099
725 Added 4.51%
16,809 $1.63 Million
Q2 2023

Jul 19, 2023
BUY
$100.78 - $112.29 $10,178 - $11,341
101 Added 0.63%
16,084 $1.75 Million
Q1 2023

Apr 17, 2023
BUY
$96.86 - $114.01 $29,251 - $34,431
302 Added 1.93%
15,983 $1.62 Million
Q4 2022

Jan 17, 2023
SELL
$95.06 - $111.52 $19,962 - $23,419
-210 Reduced 1.32%
15,681 $1.72 Million
Q3 2022

Oct 14, 2022
BUY
$96.76 - $112.03 $28,640 - $33,160
296 Added 1.9%
15,891 $1.54 Million
Q2 2022

Jul 18, 2022
SELL
$102.07 - $123.37 $75,123 - $90,800
-736 Reduced 4.51%
15,595 $1.69 Million
Q1 2022

Apr 25, 2022
SELL
$114.02 - $139.04 $140,016 - $170,741
-1,228 Reduced 6.99%
16,331 $1.93 Million
Q4 2021

Jan 25, 2022
BUY
$115.53 - $141.46 $130,086 - $159,283
1,126 Added 6.85%
17,559 $2.47 Million
Q3 2021

Oct 21, 2021
SELL
$116.66 - $129.06 $95,661 - $105,829
-820 Reduced 4.75%
16,433 $1.94 Million
Q2 2021

Jul 19, 2021
BUY
$105.79 - $124.53 $105,155 - $123,782
994 Added 6.11%
17,253 $2 Million
Q1 2021

Apr 19, 2021
BUY
$108.84 - $128.23 $84,459 - $99,506
776 Added 5.01%
16,259 $1.95 Million
Q4 2020

Jan 14, 2021
SELL
$105.0 - $114.42 $36,330 - $39,589
-346 Reduced 2.19%
15,483 $1.7 Million
Q3 2020

Oct 19, 2020
SELL
$91.64 - $111.29 $102,545 - $124,533
-1,119 Reduced 6.6%
15,829 $1.72 Million
Q2 2020

Jul 28, 2020
SELL
$76.57 - $98.0 $7,963 - $10,192
-104 Reduced 0.61%
16,948 $1.55 Million
Q1 2020

Apr 20, 2020
SELL
$62.82 - $91.86 $14,888 - $21,770
-237 Reduced 1.37%
17,052 $1.35 Million
Q4 2019

Jan 27, 2020
SELL
$78.51 - $87.4 $40,668 - $45,273
-518 Reduced 2.91%
17,289 $1.5 Million
Q3 2019

Oct 16, 2019
SELL
$81.84 - $88.74 $545,790 - $591,807
-6,669 Reduced 27.25%
17,807 $1.49 Million
Q2 2019

Jul 08, 2019
BUY
$72.88 - $85.0 $30,245 - $35,275
415 Added 1.72%
24,476 $2.06 Million
Q1 2019

Apr 23, 2019
SELL
$66.22 - $80.06 $8,741 - $10,567
-132 Reduced 0.55%
24,061 $1.92 Million
Q4 2018

Jan 17, 2019
SELL
$65.56 - $74.27 $148,624 - $168,370
-2,267 Reduced 8.57%
24,193 $1.75 Million
Q3 2018

Oct 09, 2018
SELL
$60.81 - $73.36 $10,763 - $12,984
-177 Reduced 0.66%
26,460 $1.94 Million
Q2 2018

Jul 23, 2018
SELL
$57.57 - $63.54 $110,764 - $122,250
-1,924 Reduced 6.74%
26,637 $1.63 Million
Q1 2018

Apr 23, 2018
SELL
$56.27 - $63.62 $69,774 - $78,888
-1,240 Reduced 4.16%
28,561 $1.71 Million
Q4 2017

Jan 24, 2018
BUY
$53.68 - $57.47 $49,815 - $53,332
928 Added 3.21%
29,801 $1.7 Million
Q3 2017

Oct 19, 2017
BUY
$48.06 - $53.64 $1.39 Million - $1.55 Million
28,873
28,873 $1.54 Million

Others Institutions Holding ABT

# of Institutions
3,133
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.17M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $204B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Douglas Lane & Associates, LLC Portfolio

Follow Douglas Lane & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email